Drug intelligence / Profile preview

thujopsene

Development stage
Preclinical
Lead developer
Toho University
Modality
Small Molecules
Administration
Inhalation
01

Overview

Thujopsene is a natural sesquiterpene isolated from the essential oil of the Hiba tree (*Thujopsis dolabrata*). It is being investigated for its anti-tumor properties, particularly against glioblastoma, gastric cancer, and breast cancer. Research conducted at Toho University indicates that thujopsene inhibits tumor cell proliferation more potently than hinokitiol, another component of Hiba oil. Its mechanism of action involves the induction of apoptosis through the activation of caspase-3 and caspase-9. DARTS analysis has identified Pyruvate Kinase M2 (PKM2) as a specific intracellular binding protein, suggesting that thujopsene's anti-tumor effects are mediated through the modulation of this metabolic enzyme. Due to its low molecular weight and high volatility, it is being explored for potential application in inhalation-based "aroma therapy" for brain tumors.

Other names
thujopsen(-)-thujopsene
02

Targets

CASP9 (Caspase-9)PKM2 (Pyruvate kinase M2 isoform)CASP3 (Caspase-3)

Beyond the preview

Go deeper on thujopsene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thujopsene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call